140 related articles for article (PubMed ID: 30868837)
1. [Prolonged treatment with dalbavancin in prosthetic hip infection by methicillin-resistant Staphylococcus epidermidis].
Trujillano Ruiz A; Mesquida Riera J; Serrano Fabiá MA; Riera Pérez E; Mejía Benard A; Taberner Ferrer MD
Rev Esp Quimioter; 2019 Apr; 32(2):203-204. PubMed ID: 30868837
[No Abstract] [Full Text] [Related]
2. Dalbavancin combined with linezolid in prosthetic-hip infection.
Carrión Madroñal IM; Sánchez Del Moral R; Abad Zamora JM; Martínez Marcos FJ
Rev Esp Quimioter; 2020 Apr; 33(2):147-148. PubMed ID: 32157859
[No Abstract] [Full Text] [Related]
3. Dalbavancin treatment of prosthetic knee infection due to oxacillin-resistant Staphylococcus epidermidis.
Ramírez Hidalgo M; Jover-Sáenz A; García-González M; Barcenilla-Gaite F
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Feb; 36(2):142-143. PubMed ID: 28600171
[No Abstract] [Full Text] [Related]
4. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections.
Fernández J; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):449-51. PubMed ID: 27241369
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of methicillin-resistant Staphylococcus epidermidis prosthetic joint infection with telavancin.
Kaushal R; Hassoun A
J Antimicrob Chemother; 2012 Aug; 67(8):2052-3. PubMed ID: 22544850
[No Abstract] [Full Text] [Related]
6. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties.
James PJ; Butcher IA; Gardner ER; Hamblen DL
J Bone Joint Surg Br; 1994 Sep; 76(5):725-7. PubMed ID: 8083259
[TBL] [Abstract][Full Text] [Related]
7. [Methicillin resistant staphylococci].
Afanas'eva TI
Antibiot Khimioter; 1998; 43(6):29-31. PubMed ID: 9644532
[No Abstract] [Full Text] [Related]
8. Successful treatment of right-sided prosthetic valve endocarditis due to methicillin-resistant teicoplanin-heteroresistant Staphylococcus aureus with linezolid.
Souli M; Pontikis K; Chryssouli Z; Galani I; Giamarellou H
Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):760-2. PubMed ID: 16283218
[No Abstract] [Full Text] [Related]
9. Dalbavancin treatment of methicillin-susceptible Staphylococcus aureus pyomyositis with torpid evolution: a case report.
Álvarez Otero J; Sanjurjo Rivo A; Lamas Ferreiro JL; de la Fuente Aguado J
Rev Esp Quimioter; 2019 Jun; 32(3):276-277. PubMed ID: 31037932
[No Abstract] [Full Text] [Related]
10. Staphylococcus aureus versus Staphylococcus epidermidis in periprosthetic joint infection-Outcome analysis of methicillin-resistant versus methicillin-susceptible strains.
Hischebeth GT; Randau TM; Ploeger MM; Friedrich MJ; Kaup E; Jacobs C; Molitor E; Hoerauf A; Gravius S; Wimmer MD
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):125-130. PubMed ID: 30266398
[TBL] [Abstract][Full Text] [Related]
11. Linezolid treatment of total prosthetic knee infection due to methicillin-resistant Staphylococcus epidermidis.
Jover-Sáenz A; Gaite FB; Ribelles AG; Porcel-Pérez JM; Garrido-Calvo S
J Infect; 2003 Jul; 47(1):87-8. PubMed ID: 12850170
[No Abstract] [Full Text] [Related]
12. [Linezolid-resistant Staphylococcus epidermidis in a patient with prosthetic joint].
Zamora-López MJ; Álvarez-García P; Martínez-López J; Pallarés-González MA; García-Campello M
Rev Esp Quimioter; 2016 Jun; 29(3):159-60. PubMed ID: 27015821
[No Abstract] [Full Text] [Related]
13.
Plota M; Papadimitriou-Olivgeris M; Kolonitsiou F; Tsiata E; Spiliopoulou I; Assimakopoulos SF; Marangos M
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34559042
[No Abstract] [Full Text] [Related]
14. Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept.
Cojutti PG; Rinaldi M; Gatti M; Tedeschi S; Viale P; Pea F
Int J Antimicrob Agents; 2021 Nov; 58(5):106445. PubMed ID: 34614441
[TBL] [Abstract][Full Text] [Related]
15. Treatment with dalbavancin in a patient with septic thrombophlebitis of the internal jugular vein due to Staphylococcus aureus after insertion of an implantable cardioverter defibrillator.
Martínez-Sanz J; Gijón de la Santa L; Torralba M
Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(6):389-390. PubMed ID: 29132942
[No Abstract] [Full Text] [Related]
16. Results of periprosthetic hip and knee infections caused by resistant bacteria.
Kilgus DJ; Howe DJ; Strang A
Clin Orthop Relat Res; 2002 Nov; (404):116-24. PubMed ID: 12439249
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.
Tevell S; Claesson C; Hellmark B; Söderquist B; Nilsdotter-Augustinsson Å
Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):911-7. PubMed ID: 24338092
[TBL] [Abstract][Full Text] [Related]
18. Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.
Elsaghier AA; Aucken HM; Hamilton-Miller JM; Shaw S; Kibbler CC
J Antimicrob Chemother; 2002 Feb; 49(2):423-4. PubMed ID: 11815594
[No Abstract] [Full Text] [Related]
19. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
[TBL] [Abstract][Full Text] [Related]
20. Local treatment of Dacron patch graft infected with biofilm-producing Staphylococcus epidermidis using antibiotic-releasing porous apatite ceramic: an experimental study in the rabbit.
Shimabukuro K; Hirose H; Mori Y; Takagi H; Iwata H; Kawamura Y
J Vasc Surg; 2004 Jun; 39(6):1361. PubMed ID: 15206415
[No Abstract] [Full Text] [Related]
[Next] [New Search]
